Reshaping Rx: Navigating 2025 Drug Pricing Policies Webinar on June 26 at 12:00 PM EDT
Join us for a free webinar as experts break down the latest federal and state policy developments shaping the pharmaceutical landscape in 2025. We’ll explore what these shifts mean for manufacturers, payers, providers, and patients.
Democratic Doctors Caucus Reaffirms EMTALA Amid Trump's CMS Policy Reversal on Abortion Care
Addressing Barriers to Hispanic Men's Engagement in Diabetes Prevention
Scaling Early Palliative Care in Value-Based Community Oncology: A Technology-Enabled Approach
10 Years of Coverage Gains Threatened by Proposed Federal Policy Changes, Report Finds
Hospital Management Involvement Impacts Health-Related Social Needs Program Adoption
Managed Care Cast News Roundup: June 17, 2025
Workforce Technology Eases Staffing Shortages in Rural Health Care
Health Equity & Access Weekly Roundup: June 16, 2025
Supreme Court to Rule Whether Pro-Life Pregnancy Center Can Avoid Subpoena
Disparities, Worsening Inequality of Growing RA Burden, Reveals AI-Driven Study
IV vs Subcutaneous: Clinical Considerations
Inflation Reduction Act: Clinical Challenges
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
Lenacapavir Approval Could Change Course of Treating, Preventing HIV: Gordon Crofoot, MD, PA
The Pharmacist’s Role in Value-Based Oncology Models: David Awad, PharmD, BCOP
Combination of Garadacimab, Sebetralstat Can Help Patients With HAE: Timothy Craig, DO
Cost and Infrastructure Slow Cardiac PET Adoption: Merrill Stewart, MD
Workflow Wins: Scheduling and Pharmacy Impact
DVRd vs VRd in Transplant-Ineligible Myeloma: Insights From Saad Z. Usmani, MD, MBA
Breast Cancer and the Use of Predictive Genomics
Scaling Early Palliative Care in Value-Based Community Oncology: A Technology-Enabled Approach
Risk Factors for Financial Toxicity in Health Care
Outcomes for Hospitals Participating in More- and Less-Mature ACOs
Factors Associated With Unplanned Admissions Among Patients With Chronic Conditions
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Weighing Drug Costs and Patient Values in Cancer Care
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
Navigating Next-Generation Therapies for the Management of Acid-Related Disorders
